No label defined (Q2720782)

From EU Knowledge Graph
Revision as of 18:35, 31 May 2021 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Investigation of the predictive and prognostic role of liquid biopsies in patients with non-small cell lung cancer treated with anti-PD-1-inhibitor, pembrolizumab, translated_summary)
Jump to navigation Jump to search
Project Q2720782 in Cyprus
Language Label Description Also known as
English
No label defined
Project Q2720782 in Cyprus

    Statements

    country
    Cyprus
    0 references
    EU contribution
    195,564.6 Euro
    0 references
    budget
    230,076.0 Euro
    0 references
    co-financing rate
    85.0 percent
    0 references
    start time
    25 January 2019
    0 references
    end time
    1 February 2022
    0 references
    beneficiary name (string)
    University of Cyprus
    0 references
    summary
    Διερεύνηση του προβλεπτικού και προγνωστικού ρόλου των υγρών βιοψιών σε ασθενείς με μη μικροκυτταρικό καρκίνο του πνεύμονα που παίρνουν θεραπεία με τον άντι-PD-1-αναστολέα, Pembrolizumab (Greek)
    0 references
    Investigation of the predictive and prognostic role of liquid biopsies in patients with non-small cell lung cancer treated with anti-PD-1-inhibitor, pembrolizumab (English)
    point in time
    31 May 2021
    0 references
    location (string)
    *Δεν έχει γεωγραφική διάσταση*
    0 references

    Identifiers

    Cypriot Kohesio ID
    34474
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2720782&oldid=9772788"